Cormorant Asset Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.68M | Sell |
|
|||||
|
2025
Q1 | $11.8M | Sell |
|
|||||
|
2024
Q4 | $30.5M | Hold |
|
|||||
|
2024
Q3 | $48.2M | Buy |
|
|||||
|
2024
Q2 | $17.4M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $11.2M | Sell |
|
|||||
|
2023
Q2 | $29M | Hold |
|
|||||
|
2023
Q1 | $40.1M | Sell |
|
|||||
|
2022
Q4 | $61.3M | Buy |
|
|||||
|
2022
Q3 | $32.9M | Hold |
|
|||||
|
2022
Q2 | $29.2M | Hold |
|
|||||
|
2022
Q1 | $37.2M | Hold |
|
|||||
|
2021
Q4 | $47.8M | Sell |
|
|||||
|
2021
Q3 | $53.3M | Sell |
|
|||||
|
2021
Q2 | $55.1M | Sell |
|
|||||
|
2021
Q1 | $53.8M | Sell |
|
|||||
|
2020
Q4 | $62.9M | Sell |
|
|||||
|
2020
Q3 | $69.5M | Sell |
|
|||||
|
2020
Q2 | $67.8M | Buy |
|